Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.

Inclusion Criteria:

• Must have completed the double-blind portion of the preceding trial
• Completed any protocol specified withdrawal phase and follow-up visits.

Exclusion Criteria:

• Patient cannot participate if they experienced a serious adverse event or a nonserious, but medically significant adverse event during the preceding efficacy study that was judged to be related to the study medication.